Jasmin Mann

ORCID: 0000-0002-8934-0639
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Childhood Cancer Survivors' Quality of Life
  • Family and Disability Support Research
  • Calcium signaling and nucleotide metabolism
  • Dermatology and Skin Diseases
  • melanin and skin pigmentation
  • Skin Protection and Aging
  • Lysosomal Storage Disorders Research
  • RNA regulation and disease
  • Neurogenetic and Muscular Disorders Research
  • Erythrocyte Function and Pathophysiology
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Advancements in Transdermal Drug Delivery
  • Immunodeficiency and Autoimmune Disorders
  • Psoriasis: Treatment and Pathogenesis
  • Cytomegalovirus and herpesvirus research

University of Freiburg
2021-2025

University of Konstanz
2021

Colchester Hospital
2006

St Bartholomew's Hospital
2006

Genetic screening for severe congenital immuno-hematological diseases offers potential early intervention, particularly through preemptive allogeneic stem cell transplantation (HSCT). However, the clinical value of such depends on precise prognostic predictions based genotype-phenotype correlations and/or functional confirmation. We investigated familial hemophagocytic lymphohistiocytosis type 2 (FHL2), caused by PRF1 variants. Specifically we evaluated significance frequent A91V variant, if...

10.1182/blood.2024027954 article EN cc-by-nc-nd Blood 2025-03-16

Hermansky-Pudlak syndrome (HPS), a rare heterogeneous autosomal recessive disorder, is characterized by oculocutaneous albinism (OCA) and bleeding diathesis due to defect regarding melanosomes platelet delta (δ)-granule secretion. Interestingly, patients with HPS type 2 (HPS-2) or 10 (HPS-10) present additionally an immunological defect. We investigated three (IP1, IP2, IP3) who suffer from diathesis. Platelet aggregometry showed impaired function flow cytometry revealed severely reduced...

10.3389/fphar.2021.786937 article EN cc-by Frontiers in Pharmacology 2022-01-19

Hemophagocytic lymphohistiocytosis (HLH) is a disorder of uncontrolled immune activation with distinct clinical features including fever, cytopenia, splenomegaly, and sepsis-like symptoms. In young adolescent patient novel germline GATA2 variant (NM_032638.5 (GATA2): c.177C>G, p.Tyr59Ter) was discovered had resulted in non-tuberculous mycobacterial (NTM) infection aggressive HLH. Strikingly, impaired degranulation cytotoxic T-lymphocytes (CTL) natural killer (NK)-cells detected...

10.3389/fimmu.2021.682934 article EN cc-by Frontiers in Immunology 2021-05-10

ABSTRACT Primary hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome caused by inborn errors of cytotoxicity. Patients with biallelic PRF1 null mutations (encoding perforin) usually develop excessive immune cell activation, hypercytokinemia, and immunopathology in the first 6 months life, often without an apparent infectious trigger. In contrast, perforin‐deficient (PKO) mice only HLH after systemic infection lymphocytic choriomeningitis virus (LCMV). We...

10.1002/eji.202451061 article EN cc-by European Journal of Immunology 2024-11-16

ABSTRACT Occasional serum samples (<0.5%) tested by indirect immunofluorescence showed less fluorescence than did negative-control serum. A retrospective review of these patients' immunoglobulins revealed a high percentage abnormalities (71%, versus 22% controls). We suggest that this observation should be reported when seen and the clinician alerted to an association with immunoglobulin abnormalities.

10.1128/cvi.00218-06 article EN Clinical and Vaccine Immunology 2006-11-01
Coming Soon ...